JPMorgan Chase & Co’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $176K | Buy |
|
|||||
|
2025
Q2 | $74.4K | Sell |
|
|||||
|
2025
Q1 | $180K | Buy |
|
|||||
|
2024
Q4 | $68.6K | Sell |
|
|||||
|
2024
Q3 | $63.8K | Buy |
|
|||||
|
2024
Q2 | $104K | Sell |
|
|||||
|
2024
Q1 | $543K | Sell |
|
|||||
|
2023
Q4 | $1.45M | Sell |
|
|||||
|
2023
Q3 | $20.1M | Sell |
|
|||||
|
2023
Q2 | $24.5M | Sell |
|
|||||
|
2023
Q1 | $40.9M | Sell |
|
|||||
|
2022
Q4 | $51.5M | Buy |
|
|||||
|
2022
Q3 | $58.9M | Sell |
|
|||||
|
2022
Q2 | $47M | Sell |
|
|||||
|
2022
Q1 | $84.9M | Sell |
|
|||||
|
2021
Q4 | $107M | Sell |
|
|||||
|
2021
Q3 | $115M | Buy |
|
|||||
|
2021
Q2 | $84.3M | Buy |
|
|||||
|
2021
Q1 | $75.9M | Buy |
|
|||||
|
2020
Q4 | $86.1M | Buy |
|
|||||
|
2020
Q3 | $89M | Buy |
|
|||||
|
2020
Q2 | $81M | Buy |
|
|||||
|
2020
Q1 | $66.9M | Buy |
|
|||||
|
2019
Q4 | $62.3M | Sell |
|
|||||
|
2019
Q3 | $74.4M | Sell |
|
|||||
|
2019
Q2 | $91.6M | Sell |
|
|||||
|
2019
Q1 | $64.7M | Buy |
|
|||||
|
2018
Q4 | $33.8M | Buy |
|
|||||
|
2018
Q3 | $36.1M | Sell |
|
|||||
|
2018
Q2 | $31.3M | Buy |
|
|||||
|
2018
Q1 | $22.6M | Buy |
|
|||||
|
2017
Q4 | $16.9M | Buy |
|
|||||
|
2017
Q3 | $23.6M | Buy |
|
|||||
|
2017
Q2 | $20M | Sell |
|
|||||
|
2017
Q1 | $34.5M | Buy |
|
|||||
|
2016
Q4 | $44.1M | Sell |
|
|||||
|
2016
Q3 | $51.7M | Buy |
|
|||||
|
2016
Q2 | $31.7M | Sell |
|
|||||
|
2016
Q1 | $45.1M | Buy |
|
|||||
|
2015
Q4 | $38M | Buy |
|
|||||
|
2015
Q3 | $27.6M | Sell |
|
|||||
|
2015
Q2 | $44.1M | Buy |
|
|||||
|
2015
Q1 | $39.3M | Buy |
|
|||||
|
2014
Q4 | $12M | Buy |
|